Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:CEO |
gptkb:Chris_Hall
|
| gptkbp:focusesOn |
precision medicine
cancer genomics |
| gptkbp:foundedYear |
2011
|
| gptkbp:headquartersLocation |
gptkb:Menlo_Park,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Personalis
|
| gptkbp:industry |
gptkb:biotechnology
genomics |
| gptkbp:listedOn |
gptkb:NASDAQ
|
| gptkbp:provides |
bioinformatics solutions
genomic sequencing services |
| gptkbp:publiclyTraded |
yes
|
| gptkbp:serves |
research institutions
healthcare providers biopharmaceutical companies |
| gptkbp:specializesIn |
immuno-oncology
next-generation sequencing |
| gptkbp:stockSymbol |
gptkb:PSNL
|
| gptkbp:website |
https://www.personalis.com/
|
| gptkbp:bfsParent |
gptkb:Casdin_Capital
|
| gptkbp:bfsLayer |
6
|